Insights

Strategic Partnerships HelixNano is actively exploring collaboration with Medicus Pharma to co-develop thermostable infectious disease vaccines using its mRNA platform, indicating a near-term avenue for partnership discussions and joint ventures.

Platform Value The company positions itself around an advanced mRNA platform aimed at enabling previously impossible applications across human and non-human biology, suggesting sales opportunities for platform licensing, custom vaccine development, and research collaborations.

Funding & Scale With revenue in the low millions and $60M in funding, HelixNano demonstrates early-stage financial backing and potential for follow-on investment rounds or co-development funding from partners seeking rapid R&D milestones.

Vaccine Focus Past press indicates work on multi-antigen vaccines and SARS-CoV-2 related vaccines, signaling opportunities for bio/pharma customers seeking next-generation vaccine platforms, thermostable delivery, and rapid response capabilities.

Talent & Growth Small-to-mid-sized team (11-50 employees) in biotech with ambitious R&D objectives, presenting target opportunities for contract research, CRO/CMO partnerships, and joint development programs to scale capabilities.

HelixNano Tech Stack

HelixNano uses 8 technology products and services including Squarespace, WordPress, Webpack, and more. Explore HelixNano's tech stack below.

Squarespace

Content Management System

WordPress

Content Management System

Webpack

Development

Dropbox

Digital Asset Management

Squarespace Commerce

E-commerce

Google Workspace

jQuery

Javascript Libraries

ZURB Foundation

UI Frameworks

HelixNano Email Formats	Example	Percentage
First@helixnano.com	John@helixnano.com	100%

HelixNano Email Formats

Example

Percentage

First@helixnano.com

John@helixnano.com

100%

Frequently Asked Questions

What is HelixNano's official website and social media links?

HelixNano's official website is helixnano.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does HelixNano generate?

As of September 2026, HelixNano's annual revenue is estimated to be $1M - $10M.

What is HelixNano's SIC code and NAICS code?

HelixNano's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does HelixNano have currently?

As of September 2026, HelixNano has approximately 15 employees across 1 continents, including North America. Key team members include Research Scientist - Immune And In Vivo Inquirer: D. D. J. D. P. Explore HelixNano's employee directory with LeadIQ.

What industry does HelixNano belong to?

HelixNano operates in the Biotechnology Research industry.

What technology does HelixNano use?

HelixNano's tech stack includes Squarespace, WordPress, Webpack, Dropbox, Squarespace Commerce, Google Workspace, jQuery and ZURB Foundation.

What is HelixNano's email format?

HelixNano's email format typically follows the pattern of First@helixnano.com. Find more HelixNano email formats with LeadIQ.

How much funding has HelixNano raised to date?

As of September 2026, HelixNano has raised $60M in funding. The last funding round occurred on Apr 04, 2024.

When was HelixNano founded?

HelixNano was founded in 2013.

HelixNano

Q: What is HelixNano's official website and social media links?

HelixNano's official website is helixnano.com. HelixNano has social profiles on LinkedIn.

Q: How many employees does HelixNano have currently?

HelixNano has approximately 15 employees.

Q: What technology does HelixNano use?

HelixNano's tech stack includes Priority Hints, WordPress, jQuery, Adobe Fonts, Google Analytics.

Q: What is HelixNano's NAICS code?

HelixNano's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMassachusetts, United States11-50 Employees

HelixNano is a biotechnology research company based in Cambridge, Massachusetts, focused on developing an advanced mRNA platform to enable applications across human and non-human biology. The firm aims to advance vaccine and therapeutic possibilities by leveraging its mRNA technology, addressing needs in infectious disease and related areas. Its work sits in the biotech sector, where it positions itself alongside other organizations pursuing novel mRNA-based solutions, with a emphasis on enabling previously difficult-to-achieve capabilities. The company operates from the Boston area and is small to mid-sized, reflecting a focused team pursuing early-stage development. A recent development involves a non-binding memorandum of understanding with Medicus Pharma to explore thermostable infectious disease vaccines by combining HelixNano’s mRNA platform with Medicus’ delivery approach, signaling collaboration in the field.

Insights

Similar companies to HelixNano

Moderna

Arcturus Therapeutics

CureVac

HelixNano Tech Stack

Media & News

Eroshenko left Helixnano on Jul 1st '25.

Rajaniemi left Helixnano on Jul 1st '25.

Helixnano integrates with Medicus Pharma Ltd..

Helixnano is developing multi-antigen mRNA vaccine.

Helixnano is developing vaccine.

HelixNano's Email Address Formats